EXOMIND TMS Therapy at Azzolino Clinic
Non-invasive neuromodulation integrated with our BRAIN360® neurological wellness program
EXOMIND™ is an FDA-cleared transcranial magnetic stimulation (TMS) system designed to stimulate specific brain networks involved in emotional regulation and cognitive function. At the Azzolino Clinic, EXOMIND TMS is offered as part of our BRAIN360® program — a comprehensive approach to neurological wellness combining functional neurology, medical and naturopathic care.
What Is EXOMIND TMS?
EXOMIND TMS uses focused electromagnetic pulses to stimulate the dorsolateral prefrontal cortex (DLPFC), a region of the brain associated with mood regulation and executive function. This technique is based on decades of published research on transcranial magnetic stimulation and its effects on neural activity and neuroplasticity.
Key features:
- Non-invasive and medication-free
- Sessions typically last about 30 minutes
- No anesthesia or recovery time required
How Transcranial Magnetic Stimulation Works
Transcranial magnetic stimulation delivers brief magnetic pulses through the scalp to influence neuronal signaling in targeted brain regions. Depending on protocol and location, stimulation can increase or decrease neural activity.
Published clinical research shows that TMS can:
- Modulate brain network connectivity
- Support neuroplastic changes
- Influence regions involved in emotional processing
TMS is one of the most studied non-invasive neuromodulation techniques currently in clinical use.
ExoMind TMS Stimulates the Brain’s Regulatory Center
ExoMind utilizes transcranial magnetic stimulation (TMS) to target and activate key regulatory regions of the brain — particularly the orbitofrontal cortex (OFC).
The orbitofrontal cortex is part of the brain’s executive and emotional control network. It plays a critical role in:
• Emotional regulation
• Impulse control
• Reward processing
• Stress modulation
• Decision-making
• Behavioral flexibility
When this region is underactive or dysregulated, individuals may experience difficulty with mood stability, cravings, compulsive behaviors, anxiety, or reduced cognitive control.
Symptoms of Depression
Mental Wellness
Food Cravings
Binge Eating
Sleep and Stress
Willpower and Self-Control
Published Clinical Research on ExoMind
ExoMind is built on the established science of transcranial magnetic stimulation (TMS), a non-invasive neuromodulation technology extensively studied in clinical neuroscience for over two decades. Peer-reviewed research demonstrates that targeted stimulation of frontal regulatory networks can modulate cortical activity and improve functional connectivity within brain circuits responsible for mood, executive control, and behavioral regulation. These effects are measurable using validated clinical assessments and neurophysiological markers.
Transcranial magnetic stimulation devices are FDA-cleared in the United States for the treatment of Major Depressive Disorder (MDD) in adults. Additional TMS technologies have also received FDA clearance for obsessive-compulsive disorder (OCD), migraine with aura, and smoking cessation support.
EXOMIND TMS and the BRAIN360® Program
At the Azzolino Clinic, EXOMIND TMS is not just a stand-alone treatment. It is strategically integrated into our BRAIN360® neurological rehabilitation framework, where care is guided by objective neurological findings and individualized functional assessments.
Brain360® is designed to restore deficient neural pathways through a comprehensive, systems-based approach that combines advancements in functional neurology, functional medicine, and traditional medical care. Each program is tailored to address the specific networks within the brain and nervous system that require support.
Depending on clinical presentation and goals, a BRAIN360® program may include:
• Head-to-toe comprehensive functional neurological examination
• Advanced functional medicine testing to identify inflammation, toxicities, and metabolic contributors
• Targeted neurorehabilitation and movement-based therapies
• Integrated precise chiropractic adjustments and musculoskeletal optimization
• EXOMIND TMS when clinically appropriate
By integrating neuromodulation with movement therapy, metabolic optimization, and neurological rehabilitation, we create measurable improvements in brain function — all within a coordinated, patient-centered model of care.
Frequently Asked Questions
What Should I Expect During EXOMIND TMS Treatment?
Before Treatment
- BRAIN360® neurological evaluation
- Review of medical history
- Personalized care planning
During Treatment
- Comfortable seated session
- Gentle tapping or tingling sensation
- Approximately 30 minutes per session
After Treatment
- Resume normal activities immediately
- Ongoing progress monitoring
What is the difference between EXOMIND and traditional TMS?
Traditional Transcranial Magnetic Stimulation (TMS) is commonly used for depression and typically requires daily treatments over 4–6 weeks.
EXOMIND builds on the same proven neurophysiological principles of TMS but incorporates refinements in coil engineering, pulse delivery, and treatment design that allow for a more structured and efficient treatment series.
The key difference for patients:
Traditional TMS often requires 20–36+ sessions
EXOMIND treatment plans may involve as few as six sessions, depending on clinical findings
Both approaches use non-invasive magnetic stimulation to influence brain activity.
EXOMIND is designed to deliver this stimulation in a more streamlined and targeted way, often reducing the overall treatment burden.
Is EXOMIND covered by insurance?
Insurance coverage for transcranial magnetic stimulation (TMS) depends on the patient’s diagnosis and individual policy. In the United States, TMS is FDA-cleared for Major Depressive Disorder (MDD), particularly in adults whose depression has not adequately responded to standard treatments such as antidepressant medications and psychotherapy.
Many insurance providers may offer coverage for treatment-resistant depression when specific medical necessity criteria are met, which often include documentation of prior medication trials and symptom severity.
Coverage for other applications may vary and is determined on a case-by-case basis. Our team can assist in verifying benefits and reviewing eligibility prior to initiating treatment.
Is the treatment painful?
No. EXOMIND TMS is generally very well tolerated. Most patients describe the sensation as a mild tapping or rhythmic pulsing on the scalp. The intensity is adjustable to maintain comfort.
No anesthesia or sedation is required, and you remain fully awake during the session. Any mild scalp sensitivity at the beginning typically decreases as you become accustomed to the treatment.
How many sessions are needed?
The number and frequency of EXOMIND TMS sessions are determined by your clinical findings and individualized BRAIN360™® care plan. Treatment protocols are tailored based on neurological evaluation, symptom presentation, and therapeutic goals.
